|
TTF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.322200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.937500E-02 |
| Normal-vs-Stage2 |
1.120000E-01 |
| Normal-vs-Stage3 |
8.122600E-03 |
| Normal-vs-Stage4 |
2.881400E-01 |
| Stage1-vs-Stage2 |
8.625600E-01 |
| Stage1-vs-Stage3 |
1.852580E-01 |
| Stage1-vs-Stage4 |
7.313800E-01 |
| Stage2-vs-Stage3 |
4.709200E-01 |
| Stage2-vs-Stage4 |
6.910000E-01 |
| Stage3-vs-Stage4 |
2.604000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.547900E-02 |
| Normal-vs-AfricanAmerican |
1.157380E-01 |
| Normal-vs-Asian |
2.067200E-01 |
| Caucasian-vs-AfricanAmerican |
9.336600E-01 |
| Caucasian-vs-Asian |
4.007500E-02 |
| AfricanAmerican-vs-Asian |
9.825900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.979800E-02 |
| Normal-vs-Female |
7.957800E-02 |
| Male-vs-Female |
4.675800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.799800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.494300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.218100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.863810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.666800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.638200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.587000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.030000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.316400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.906000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.258000E-01 |
| Normal-vs-Grade 2 |
3.888000E-02 |
| Normal-vs-Grade 3 |
1.497540E-02 |
| Normal-vs-Grade 4 |
3.325200E-01 |
| Grade 1-vs-Grade 2 |
4.229200E-01 |
| Grade 1-vs-Grade 3 |
3.181400E-01 |
| Grade 1-vs-Grade 4 |
6.216800E-01 |
| Grade 2-vs-Grade 3 |
5.579000E-01 |
| Grade 2-vs-Grade 4 |
6.347400E-01 |
| Grade 3-vs-Grade 4 |
4.324000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.731510E-02 |
| Normal-vs-ccB subtype |
1.808170E-01 |
| ccA subtype-vs-ccB subtype |
3.830800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.045200E-01 |
| Normal-vs-N1 |
7.180200E-01 |
| N0-vs-N1 |
2.825200E-01 |
|
|
